$TRUG
Trugolf Holdings Inc Stock $trug

$trug Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224032270 Filed on August 14, 2024

Income Statement

Concept	2024 Q1	2023 Q1
Revenue	$538.4K	$0.00
YoY Change
Cost Of Revenue	$1.959M	$1.142M
YoY Change	71.58%
Gross Profit	$3.053M	$3.941M
YoY Change	-22.54%
Gross Profit Margin	567.02%
Selling, General & Admin	$1.825M	$764.2K
YoY Change	138.84%	331.68%
% of Gross Profit	59.78%	19.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$14.32K	$10.34K
YoY Change	38.46%
% of Gross Profit	0.47%	0.26%
Operating Expenses	$3.997M	$764.2K
YoY Change	422.98%	331.68%
Operating Profit	-$943.7K	-$4.905M
YoY Change	-80.76%
Interest Expense	$96.51K	$95.76K
YoY Change	0.78%	-1615.19%
% of Operating Profit
Other Income/Expense, Net	-$358.2K	-$446.7K
YoY Change	-19.81%
Pretax Income		-$668.5K
YoY Change		264.58%
Income Tax		-$10.85K
% Of Pretax Income
Net Earnings	-$1.302M	-$657.6K
YoY Change	97.97%	258.66%
Net Earnings / Revenue	-241.79%
Basic Earnings Per Share	-$0.22	-$446.20
Diluted Earnings Per Share	-$0.22	-$0.14
COMMON SHARES
Basic Shares Outstanding	5.995M shares	11.99K shares
Diluted Shares Outstanding	5.995M shares	11.99K shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.826M	$9.756M
YoY Change	-19.79%	-92.42%
Cash & Equivalents	$7.826M	$595.5K
Short-Term Investments	$0.00	$9.161M
Other Short-Term Assets		$20.41K
YoY Change		-93.53%
Inventory	$2.336M
Prepaid Expenses		$20.41K
Receivables	$3.317M
Other Receivables
Total Short-Term Assets		$9.777M
YoY Change		-92.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$166.7K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.906M
YoY Change
Total Long-Term Assets		$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets		$9.777M
Total Long-Term Assets		$0.00
Total Assets		$9.777M
YoY Change		-92.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses		$866.5K
YoY Change		5414.89%
Deferred Revenue	$1.795M
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$1.865M
YoY Change		273.0%
Total Short-Term Liabilities	$9.695M	$2.795M
YoY Change	246.85%	420.78%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities	$81.56K	$4.428M
YoY Change	-98.16%	0.0%
Total Long-Term Liabilities	$81.56K	$4.428M
YoY Change	-98.16%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.695M	$2.795M
Total Long-Term Liabilities	$81.56K	$4.428M
Total Liabilities	$24.55M	$7.223M
YoY Change	239.95%	45.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.66M	-$6.441M
YoY Change	112.1%	70.55%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$9.073M	-$6.440M
YoY Change
Total Liabilities & Shareholders Equity	$15.48M	$9.777M
YoY Change	58.34%	-92.42%

Cashflow Statement

Concept	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$1.302M	-$657.6K
YoY Change	97.97%	258.66%
Depreciation, Depletion And Amortization	$14.32K	$10.34K
YoY Change	38.46%
Cash From Operating Activities	$2.669M	-$366.6K
YoY Change	-827.86%	266.27%
INVESTING ACTIVITIES
Capital Expenditures	$332.3K	$46.65K
YoY Change	612.42%
Acquisitions
YoY Change
Other Investing Activities		$120.9M
YoY Change
Cash From Investing Activities	-$332.3K	$120.9M
YoY Change	-100.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$92.13K	-120.9M
YoY Change	-100.08%
NET CHANGE
Cash From Operating Activities	$2.669M	-366.6K
Cash From Investing Activities	-$332.3K	120.9M
Cash From Financing Activities	$92.13K	-120.9M
Net Change In Cash	$2.428M	-366.6K
YoY Change	-762.34%	266.27%
FREE CASH FLOW
Cash From Operating Activities	$2.669M	-$366.6K
Capital Expenditures	$332.3K	$46.65K
Free Cash Flow	$2.336M	-$413.3K
YoY Change	-665.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet		usd
CY2024Q1	TRUG	Margin Line Of Credit Account MarginLineOfCreditAccount		usd
CY2023Q4	TRUG	Other Accrued Liabilities Current Assumed In Merger OtherAccruedLiabilitiesCurrentAssumedInMerger		usd
CY2023Q4	TRUG	Long Term Notes Payable Assumed In Merger LongTermNotesPayableAssumedInMerger		usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	TRUG	Other Comprehensive Income Unrealized Gain In Fair Value Of Short Term Investments OtherComprehensiveIncomeUnrealizedGainInFairValueOfShortTermInvestments		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024Q1	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts		usd
CY2023Q1	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts		usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2023Q1	TRUG	Change In Other Comprehensive Income ChangeInOtherComprehensiveIncome		usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023Q1	TRUG	Proceeds Of Pipe Loan Net Of Oid Discount ProceedsOfPipeLoanNetOfOidDiscount		usd
CY2023Q1	TRUG	Payments Of Costs Of Merger From Pipe Loan PaymentsOfCostsOfMergerFromPipeLoan		usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2023Q1	TRUG	Increase In Other Liabilities IncreaseInOtherLiabilities		usd
CY2024Q1	TRUG	Payments Of Dividend PaymentsOfDividend		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Notes Issued1 NotesIssued1		usd
CY2023Q1	TRUG	Accrued Liabilities Assumed In Merger AccruedLiabilitiesAssumedInMerger		usd
CY2023Q1	TRUG	Remeasurement Of Common Stock Exchangedissued In Merger RemeasurementOfCommonStockExchangedissuedInMerger		usd
CY2024Q1	TRUG	Distributions Payments For Tax Liabilities DistributionsPaymentsForTaxLiabilities		usd
CY2023Q4	TRUG	Distributions Payments For Tax Liabilities DistributionsPaymentsForTaxLiabilities		usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	363879	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	802738	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	802738	usd
CY2023Q4	TRUG	Margin Line Of Credit Account MarginLineOfCreditAccount	1980937	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	954622	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	954622	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	542631	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	459872	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	804405	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1125495	usd
CY2024Q1	TRUG	Other Accrued Liabilities Current Assumed In Merger OtherAccruedLiabilitiesCurrentAssumedInMerger	295008	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	347809	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	334255	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9694647	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10668339	usd
CY2024Q1	TRUG	Long Term Notes Payable Assumed In Merger LongTermNotesPayableAssumedInMerger	1565000	usd
CY2024Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	4320947	usd
CY2024Q1	TRUG	Dividend Notes Payable DividendNotesPayable	4023923	usd
CY2023Q4	TRUG	Dividend Notes Payable DividendNotesPayable	4023923	usd
CY2024Q1	TRUG	Gross Sales Royalty Payable GrossSalesRoyaltyPayable	1000000	usd
CY2023Q4	TRUG	Gross Sales Royalty Payable GrossSalesRoyaltyPayable	1000000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	574363	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	668228	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	81560	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	63015	usd
CY2024Q1	us-gaap	Liabilities Liabilities	24553285	usd
CY2023Q4	us-gaap	Liabilities Liabilities	19687288	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4692	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	4692	shares
CY2024Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2037000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2037000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6623839	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10479738	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1662	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13660788	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12358924	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-9072623	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3917728	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15480662	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15769560	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5012022	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5083199	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	1959023	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1141768	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	3052999	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	3941431	usd
CY2024Q1	us-gaap	Royalty Expense RoyaltyExpense	329888	usd
CY2023Q1	us-gaap	Royalty Expense RoyaltyExpense	215632	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1841595	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2231434	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1825201	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6398885	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3996684	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	8845951	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-943685	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4904520	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	30587	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21497	usd
CY2024Q1	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	384854	usd
CY2023Q1	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	468154	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3912	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-358179	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-446657	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-1301864	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-5351177	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1301864	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5351177	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-446.15
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-446.15
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5994704	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5994704	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11994	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11994	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1301864	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5351177	usd
CY2023Q1	TRUG	Other Comprehensive Income Unrealized Gain In Fair Value Of Short Term Investments OtherComprehensiveIncomeUnrealizedGainInFairValueOfShortTermInvestments	-11914	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1301864	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5339263	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3430759	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4493333	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-11914	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4276689	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3917728	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-3917728	usd
CY2024Q1	TRUG	Realized Gain In Fair Value Of Short Term Investments RealizedGainInFairValueOfShortTermInvestments	1662	usd
CY2024Q1	TRUG	Stock Issued During Values In Common Stock Exchanged In Merger StockIssuedDuringValuesInCommonStockExchangedInMerger	-3854693	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1301864	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-9072623	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-9072623	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1301864	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5351177	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	36105	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13756	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	947	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	257233	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	82454	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	72520	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	205920	usd
CY2024Q1	TRUG	Change In Other Comprehensive Income ChangeInOtherComprehensiveIncome	1662	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	4493333	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-468422	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-367541	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	216569	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1122034	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-200278	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-70178	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2478953	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	40422	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1875000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1146347	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	526376	usd
CY2024Q1	TRUG	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	90524	usd
CY2023Q1	TRUG	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-594071	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	82759	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	128049	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-321090	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-158586	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-80311	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-65572	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2668617	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3071956	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	332342	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	46650	usd
CY2023Q1	TRUG	Payments For Proceeds From Long Term Assets PaymentsForProceedsFromLongTermAssets	2421060	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-332342	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2467710	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1875000	usd
CY2024Q1	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	15716	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2295	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	33616	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	268500	usd
CY2024Q1	TRUG	Proceeds Of Pipe Loan Net Of Oid Discount ProceedsOfPipeLoanNetOfOidDiscount	4320000	usd
CY2024Q1	TRUG	Proceeds Of Cash Acquired In Merger ProceedsOfCashAcquiredInMerger	103818	usd
CY2024Q1	TRUG	Payments Of Costs Of Merger From Pipe Loan PaymentsOfCostsOfMergerFromPipeLoan	2082787	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1980937	usd
CY2024Q1	TRUG	Increase In Other Liabilities IncreaseInOtherLiabilities	-18545	usd
CY2023Q1	TRUG	Payments Of Dividend PaymentsOfDividend	-42963	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	92128	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1884347	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2428403	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3655319	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5397564	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9656266	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7825967	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6000947	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	302095	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	275735	usd
CY2024Q1	us-gaap	Notes Issued1 NotesIssued1	1565000	usd
CY2024Q1	TRUG	Accrued Liabilities Assumed In Merger AccruedLiabilitiesAssumedInMerger	310724	usd
CY2024Q1	TRUG	Remeasurement Of Common Stock Exchangedissued In Merger RemeasurementOfCommonStockExchangedissuedInMerger	-1875724	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	103818	usd
CY2024Q1	TRUG	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net Proceeds From Investment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetProceedsFromInvestment	2237213	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	310724	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt	1565000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	465307	usd
CY2024Q1	TRUG	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt Gross BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtGross	4800000	usd
CY2024Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.10	pure
CY2024Q1	TRUG	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Unamortized Discount BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnamortizedDiscount	480000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt	4320000	usd
CY2024Q1	TRUG	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Payment Of Closing Costs And Other Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesPaymentOfClosingCostsAndOtherExpenses	2082787	usd
CY2024Q1	TRUG	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities Net Proceeds From Convertible Notes Payable In Merger BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNetProceedsFromConvertibleNotesPayableInMerger	2237213	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zYruChISGh2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zlsxFK7vSic6">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the financial statements and the reported amounts of expenses during the reported period. These assumptions and estimates could have a material effect on the financial statements. Actual results may differ materially from those estimates. The Company’s management periodically reviews estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause the Company to revise these estimates. Significant estimates include estimates used in the valuation allowance related to deferred tax assets and capitalized software costs. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	7825967	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	5394564	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	6742396	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4251124	usd
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1395688	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1227135	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	448360	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	429050	usd
CY2024Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	18463	usd
CY2024Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	18463	usd
CY2024Q1	TRUG	Capitalized Software Development Costs Net CapitalizedSoftwareDevelopmentCostsNet	363889	usd
CY2023Q4	TRUG	Capitalized Software Development Costs Net CapitalizedSoftwareDevelopmentCostsNet	50000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12M
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	171502	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	171502	usd
CY2024Q1	us-gaap	Revenues Revenues	538427	usd
CY2023Q1	us-gaap	Revenues Revenues	538427	usd
CY2024Q1	us-gaap	Royalty Expense RoyaltyExpense	329888	usd
CY2023Q1	us-gaap	Royalty Expense RoyaltyExpense	215632	usd
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_ztxwWlOdCXzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zQl46Bs9KaDk">Concentration of Credit and Supplier Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash deposits and trade accounts receivable. Credit risk can be negatively impacted by adverse changes in the economy or by disruptions in the credit markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain our cash deposits with established commercial banks. At times, balances may exceed federally insured limits. We have not experienced any losses in such accounts and do not believe that we are exposed to any significant credit risk associated with our cash deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that credit risk with respect to trade accounts receivable is somewhat mitigated by our large number of geographically diverse customers and our credit evaluation procedures. We record trade accounts receivables at sales value and establish specific reserves for certain customer accounts identified as known collection problems due to insolvency, disputes or other collection issues. The amounts of the specific reserves estimated by management are determined by a loss rate model based on delinquency. We maintain reserves for potential losses. There were no customers that accounted for more than <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomersMember_z9VAzN2ydoYh" title="Concentration risk percentage"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomersMember_zHvPf4Kd8e12" title="Concentration risk percentage">10.0</span></span>% of our revenues for the three months ended March 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We purchase a significant amount of parts we consume in manufacturing our simulators from nationally known original equipment manufacturers, many of whom we have had over a <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__srt--RangeAxis__srt--MinimumMember_zdrnREnAy0L4" title="Property plant and equipment useful life">10</span> to <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__srt--RangeAxis__srt--MaximumMember_zB2MhcULWBUl" title="Property plant and equipment useful life">15</span> year relationship. While we do not have long-term contracts, we do issue purchase orders based on quoted prices terms. During the three months ended March 31, 2024, we purchased approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zJnlftEZOCfl" title="Concentration risk percentage">50.4</span>% of our assembly parts from six manufacturers. We believe that while there are alternative suppliers, for the parts and equipment, we purchase in each of the principal product categories, termination of one or more of our relationships with any of our major suppliers of equipment could have a material adverse effect on our business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Trade Receivables Held For Sale Amount TradeReceivablesHeldForSaleAmount	3316779	usd
CY2023Q4	us-gaap	Trade Receivables Held For Sale Amount TradeReceivablesHeldForSaleAmount	3458625	usd
CY2024Q1	TRUG	Other Accounts Receivable OtherAccountsReceivable	9360	usd
CY2023Q4	TRUG	Other Accounts Receivable OtherAccountsReceivable	167382	usd
CY2024Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3326138	usd
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	3626007	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1395688	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1227135	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	1930450	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2398872	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2784013	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2548134	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	448360	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	429050	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	2335653	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2119084	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	2511336	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1905983	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1905983	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1065332	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1115332	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	898666	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	881024	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	166666	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	234308	usd
CY2024Q1	us-gaap	Depreciation Depreciation	14317	usd
CY2023Q1	us-gaap	Depreciation Depreciation	10340	usd
CY2024Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	382342	usd
CY2024Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	18463	usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	363879	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1794748	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1704224	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1704224	usd
CY2024Q1	TRUG	Long Term Notes Payable Assumed In Merger LongTermNotesPayableAssumedInMerger	1565000	usd
CY2024Q1	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1565500	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	968500	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	287000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	287000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	287000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	1829500	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	802738	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	802738	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	4800	shares
CY2022Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	9600	usd
CY2022Q2	TRUG	Conversion Price Of Common Stock Percentage ConversionPriceOfCommonStockPercentage	0.70	pure
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.50	pure
CY2022Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	1387060	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	450000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	145992	usd
CY2022Q4	TRUG	Warrants And Convertible Notes WarrantsAndConvertibleNotes	445032	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	192857	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	450000	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	16480	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-07-31
CY2023Q1	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	375000	usd
CY2023Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	18000	shares
CY2024Q1	TRUG	Debt Instrument Remaining Original Issuance Discount DebtInstrumentRemainingOriginalIssuanceDiscount	0	usd
CY2023Q1	TRUG	Debt Instrument Remaining Original Issuance Discount DebtInstrumentRemainingOriginalIssuanceDiscount	0	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	0	usd
CY2022	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	0	usd
CY2021	us-gaap	Dividends Share Based Compensation Cash DividendsShareBasedCompensationCash	7395694	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	1965706	usd
CY2022	TRUG	Interest Dividend Rate Percentage InterestDividendRatePercentage	0.0600	pure
CY2024Q1	TRUG	Accrued Interest On Dividends Payable AccruedInterestOnDividendsPayable	274242	usd
CY2023Q4	TRUG	Accrued Interest On Dividends Payable AccruedInterestOnDividendsPayable	274242	usd
CY2024Q1	TRUG	Dividend Notes Payable DividendNotesPayable	4023923	usd
CY2023Q4	TRUG	Dividend Notes Payable DividendNotesPayable	4023923	usd
CY2024Q1	TRUG	Gross Sales Royalty Payable GrossSalesRoyaltyPayable	1000000	usd
CY2024Q1	TRUG	Aggregate Purchase Installment Percentage AggregatePurchaseInstallmentPercentage	75	pure
CY2024Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	750000	usd
CY2024Q1	TRUG	Aggregate Purchase Installment Percentage AggregatePurchaseInstallmentPercentage	75	pure
CY2024Q1	TRUG	Gross Sales Royalty Payable GrossSalesRoyaltyPayable	1000000	usd
CY2024Q1	TRUG	Aggregate Purchase Installment Percentage AggregatePurchaseInstallmentPercentage	75	pure
CY2024Q1	TRUG	Aggregate Purchase Installment Amount AggregatePurchaseInstallmentAmount	22500000	usd
CY2015Q2	TRUG	Royalty Percentage RoyaltyPercentage	0.024	pure
CY2024Q1	us-gaap	Payments For Royalties PaymentsForRoyalties	1000000	usd
CY2023	us-gaap	Payments For Royalties PaymentsForRoyalties	1000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	96509	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	9124	usd
CY2023Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	326515	usd
CY2023Q1	TRUG	Accrued Credit Cards AccruedCreditCards	270805	usd
CY2023Q4	TRUG	Accrued Credit Cards AccruedCreditCards	240989	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	140000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	140000	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	34921	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	43891	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	349556	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	374100	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	804405	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1125495	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	Each holder of a private right received one-tenth (1/10) of one share of DMAQ Class A common stock upon consummation of initial business combination
CY2024Q1	TRUG	Redemption Of Shares RedemptionOfShares	379687	shares
CY2024Q1	us-gaap	Cash Cash	2000000	usd
CY2024Q1	TRUG	Stock Based On Performance Including Services Percentage StockBasedOnPerformanceIncludingServicesPercentage	Once services are performed, the first consultant will be provided a 3% stock grant; while the second consultant will be provided up to 7% of stock based on performance deliverables including: 1.75% on consummation of an initial bridge loan agreement, 1.75% on engaging an investment banker, 1.75% upon filing an S-1 including financial statements and footnotes, and 1.75% upon the closing of an initial public offering. The second consultant will be provided warrants at a 20% discount to the then current price per share, for up to 2% for achieving a $250 million valuation and 3% more for a $500 million valuation, as well as another 2% for opening the first franchise location, and 3% more once 100 franchise locations have been sold. As of the date of this filing, no stock grants or awards have been issued.
CY2024Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2024Q1	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	Tax positions that meet the more likely than not threshold are then measured using a probability weighted approach recognizing the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement.
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1301864	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2024Q1	TRUG	Operating Loss Carryforwards Current OperatingLossCarryforwardsCurrent	267000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1000	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0590	pure
CY2024Q1	TRUG	Schedule Of Operating Lease Right Of Use Asset Table Text Bock ScheduleOfOperatingLeaseRightOfUseAssetTableTextBock	<p id="xdx_897_ecustom--ScheduleOfOperatingLeaseRightOfUseAssetTableTextBock_zbpeTcM8HOj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use asset:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zp977JEKC32d" style="display: none">SCHEDULE OF RIGHT OF USE ASSET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_4B2_zws3hGaNmQb5" style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_431_c20240101__20240331_eus-gaap--OperatingLeaseRightOfUseAsset_iS_zg0MfKHqLF5l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify; padding-bottom: 2.5pt">As of December 31, 2023</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">972,663</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_zCU96CtpYkG6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">82,454</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_43A_c20240101__20240331_eus-gaap--OperatingLeaseRightOfUseAsset_iE_ziY8WRiIDAw6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">As of March 31, 2024$</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">890,209</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	972663	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	82454	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	890209	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1002483	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	80311	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	922172	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	303478	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	406990	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	140163	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	144227	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	60809	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1055667	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	133495	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	922172	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	347809	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	574363	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-032270-index-headers.html	Edgar Link	pending
0001493152-24-032270-index.html	Edgar Link	pending
0001493152-24-032270.txt	Edgar Link	pending
0001493152-24-032270-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trug-20240331.xsd	Edgar Link	pending
trug-20240331_cal.xml	Edgar Link	unprocessable
trug-20240331_def.xml	Edgar Link	unprocessable
trug-20240331_lab.xml	Edgar Link	unprocessable
trug-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRUG
Trugolf Holdings Inc Stock $trug

2024 Q1 Form 10-Q Financial Statement

#000149315224032270 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRUG Trugolf Holdings Inc Stock $trug

2024 Q1 Form 10-Q Financial Statement

#000149315224032270 Filed on August 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRUG
Trugolf Holdings Inc Stock $trug